These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18052580)

  • 1. Aripiprazole and perphenazine: no difference.
    Rosenheck RA
    J Clin Psychiatry; 2007 Nov; 68(11):1812-3; author reply 1813-4. PubMed ID: 18052580
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
    Kane JM; Meltzer HY; Carson WH; McQuade RD; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2007 Feb; 68(2):213-23. PubMed ID: 17335319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The patient with schizophrenia taking aripiprazole: case report.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Dec; 17(3-4):234-5. PubMed ID: 16392433
    [No Abstract]   [Full Text] [Related]  

  • 4. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
    Guirguis-Blake J
    Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expectation and development of atypical antipsychotic drugs].
    Ther Umsch; 2004 Sep; 61(9):1 p preceding 539. PubMed ID: 15493111
    [No Abstract]   [Full Text] [Related]  

  • 6. Aripiprazole-associated seizure.
    Tsai JF
    J Clin Psychiatry; 2006 Jun; 67(6):995-6. PubMed ID: 16848662
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole-related body-weight gain and nutritional counseling.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E44-5. PubMed ID: 21677226
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole: novelty, adherence and understatement.
    Fear C
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):131. PubMed ID: 15469664
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
    Crismon ML; DeLeon A; Miller AL
    Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
    [No Abstract]   [Full Text] [Related]  

  • 10. Torticollis after low-dose aripiprazole administration in a Thai schizophrenia patient.
    Ittasakul P; Srivastava S; Hiranyatheb T; Ketter TA
    Asian J Psychiatr; 2012 Dec; 5(4):365-6. PubMed ID: 23174451
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aripiprazole in the treatment of schizophrenia].
    Bridler R
    Praxis (Bern 1994); 2005 Jun; 94(23):975-7. PubMed ID: 16001540
    [No Abstract]   [Full Text] [Related]  

  • 12. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
    Thone J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.
    Stahl SM
    J Clin Psychiatry; 2001 Dec; 62(12):923-4. PubMed ID: 11780870
    [No Abstract]   [Full Text] [Related]  

  • 14. Second generation antipsychotics--aripiprazole revisited.
    Med Lett Drugs Ther; 2005 Oct; 47(1219):81-2. PubMed ID: 16247339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient.
    Gonidakis F; Ploubidis D; Papadimitriou G
    Schizophr Res; 2008 Aug; 103(1-3):341-2. PubMed ID: 18262773
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole in chronic schizophrenia: experiences in daily practice.
    Fernald DS; van Dellen RT; Hovens JE; Loonen AJ
    Acta Psychiatr Scand; 2006 Oct; 114(4):294; author reply 294. PubMed ID: 16968370
    [No Abstract]   [Full Text] [Related]  

  • 17. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?
    DeQuardo JR
    J Clin Psychiatry; 2004 Jan; 65(1):132-3. PubMed ID: 14976671
    [No Abstract]   [Full Text] [Related]  

  • 18. Aripiprazole as a dopamine partial agonist: positive and negative effects.
    Glick ID; Duggal V; Hodulik C
    J Clin Psychopharmacol; 2006 Feb; 26(1):101-3. PubMed ID: 16415723
    [No Abstract]   [Full Text] [Related]  

  • 19. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients.
    Crossman AM; Lindenmayer JP
    J Clin Psychiatry; 2006 Jul; 67(7):1158-9. PubMed ID: 16889465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.